Europe
The Annual General Meeting of BioArctic AB on May 9, 2019, adopted instructions regarding the appointment of the Nomination Committee.
New features include upgraded refreshments and entertainment options, improved compensation, increased donor educational materials, and an expanded company website
Santhera Pharmaceuticals announces a strategic change to its management team with the appointment of Dario Eklund as CEO, effective December 1, 2019.
The newly-launched index takes a focused look at the breadth and depth of novel agents currently being developed within the most innovative pharmaceutical pipelines.
Ziextenzo (pegfilgrastim) is a long-acting version of filgrastim and is indicated to decrease the incidence of infection in cancer patients.
MilliporeSigma developed a new filtration-based manufacturing process resulting in a new, highly purified sucrose grade with reduced levels of nanoparticle impurities
Sygnature Discovery has added in-house high-throughput screening (HTS) to its range of drug discovery services.
MilliporeSigma has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications.
Zelluna Immunotherapy, the biotechnology company specialising in T-cell receptor based immunotherapies targeting a broad range of solid cancers with high unmet medical need, announces the appointment of Dr Bent Jakobsen to its board.
Company to Highlight Potential of Phase 3 Precision Antibiotic Ridinilazole at the 7th Annual C. diff. Conference and Health EXPO
PRESS RELEASES